Q3 2025 Stratec Se Earnings Call Transcript
Key Points
- Stratec SE (STSEY) reported a positive sales growth of 2.5% at a constant exchange rate, reaching EUR 175.6 million.
- The company successfully closed a EUR 125 million syndicated loan, optimizing its financing structure and providing flexibility for future development.
- There is a significant upturn in development activities and partnerships, indicating potential future growth.
- Stratec SE (STSEY) has maintained cost discipline and efficiency measures, which are expected to support margin stability.
- The company is seeing stabilization in testing volumes and a promising recovery in customer orders post-pandemic.
- Supply chain disruptions have negatively impacted sales, particularly in the immuno franchise, causing delivery shortfalls.
- The adjusted EBITDA margin declined to 7.3% from 8.8% in the prior year, affected by an unfavorable product mix and reduced high-margin sales.
- The adjusted net income decreased by 15.8% year over year, driven by a temporarily increased tax rate and supply chain issues.
- Stratec SE (STSEY) faces challenges with high inventory levels, particularly in the molecular business, which requires market demand recovery.
- The company anticipates ending the year at the lower end of its margin guidance due to ongoing headwinds and supply chain challenges.
Thank you and welcome everyone to our nine month 2025 financial results conference call. With me today are, as always, Marcus Wolfinger, CEO of Stratec, as well as our new CFO, Tanja Bücherl. Be aware that this conference is being webcast live, and you can download this presentation either from the webcast or from our website.
And of course, following the presentation, we will have a question-and-answer session as usual. Finally, please allow me to draw your attention to the Safe Harbour statement, which we have on page three of that presentation, and with this, it is now my pleasure to hand over to Marcus.
Yeah, thanks, and. Good morning in the United States and good afternoon in Europe. Before we start, ladies and gentlemen, I'm truly excited to welcome Tanya Buisel, our new CFO. From minute one, and it was clear that she brings not only a super strong financial background, but also the energy and team spirit that defines who we are.
With
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
